Genetic testing company 23andMe filed for Chapter 11 bankruptcy protection, signaling that the DNA data of its millions of users is now up for sale. This news has sparked concerns among privacy experts and advocates about the potential repercussions of the data falling into the wrong hands. The California Attorney General has warned users that their data could be sold and provided instructions on how to delete their genetic information from 23andMe’s database.
DNA data is highly sensitive, and its misuse could have serious consequences. Although 23andMe claims that there will be no change in how they store customers’ data and that they will comply with relevant U.S. laws, experts point out that genetic data held by tech companies is not subject to the same regulations as medical data held by professionals. This lack of oversight leaves users vulnerable to potential breaches and misuse of their genetic information.
Privacy advocates emphasize the importance of understanding the risks associated with sharing genetic data with corporations like 23andMe. The company has faced previous data breaches, including a hack in 2023 that exposed the data of millions of users. This incident highlighted the need for stronger protections and regulations surrounding the collection and storage of genetic information.
As 23andMe looks for potential buyers, experts caution individuals about the implications of surrendering their genetic privacy to a corporation and stress the need for stronger privacy laws to safeguard sensitive data. The sale of 23andMe serves as a reminder of the potential dangers of allowing personal information to be bought and sold without adequate protections in place.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
